South Australia, Australia

Deborah White

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Medvet Science Pty Ltd, Novartis Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah White. Retrieved from https://idiyas.com/inventor/deborah-white

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Deborah White

Introduction

Deborah White is a prominent inventor based in South Australia, AU. She has made significant contributions to the field of medicine, particularly in the treatment of Philadelphia-positive leukemia. Her innovative approach has the potential to improve the lives of many patients suffering from this condition.

Latest Patents

Deborah White holds a patent for a method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate. This invention specifically addresses the treatment of chronic myeloid leukemia (CML) in human patients. The method involves a series of steps designed to enhance the effectiveness of the treatment for those suffering from Ph+ leukemia.

Career Highlights

Throughout her career, Deborah has worked with notable companies such as Novartis AG and Medvet Science Pty Ltd. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the medical field.

Collaborations

Deborah has collaborated with esteemed colleagues, including Yanfeng Wang and Thea Kalebic. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Deborah White's work in optimizing treatments for Philadelphia-positive leukemia showcases her dedication to improving patient outcomes. Her innovative methods and collaborations highlight her significant impact in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…